TNF-α as a molecular target in bipolar disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 6, 2008, Pages 1355-1361

  Brietzke, Elisa ^a   Kapczinski, Flávio ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Bipolar disorder; Cytokines; Mood disorders; NF B; TNF

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LITHIUM; MOOD STABILIZER; TUMOR NECROSIS FACTOR ALPHA; VALPROIC ACID;

APOPTOSIS; BIPOLAR DISORDER; CELL LOSS; CELL SURVIVAL; COGNITIVE DEFECT; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; GENETIC VARIABILITY; GLIA CELL; HUMAN; MANIA; MOOD DISORDER; NERVE CELL; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; TREATMENT PLANNING;

ANIMALS; ANTIMANIC AGENTS; APOPTOSIS; BIPOLAR DISORDER; CELL SURVIVAL; COGNITION DISORDERS; CYTOKINES; HUMANS; MOOD DISORDERS; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47749101679     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.01.006     Document Type: Review

References (58)

1. Angst F., Stassen H., Clayton P., and Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 68 (2002) 167-181
2. Balakumar P., and Singh M. Anti-tumor necrosis factor-α in heart failure: future directions. Pharmacol Toxicol 99 (2006) 391-397
3. Beyer J., and Krishnam K. Volumetric brain imaging findings in mood disorders. J Bipolar Disord 4 (2002) 89-104
4. Bhardwaj A., and Aggarwal B. Receptor-mediated choreography of life and death. J Clin Immunol 23 (2003) 317-332
5. Blondeau N., Widmann C., Lazdunski M., and Heurteaux C. Activation of nuclear factor κB is a key event in brain tolerance. J Neurosci 21 (2001) 4668-4677
6. Blumberg H., Krystal J., Bansal R., Martin A., Dziura J., Durkin K., et al. Age, rapid-cycling and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biol Psychiatry 59 (2006) 611-618
7. Bournat J., Brown A., and Soler A. Wnt-1 dependent activation of the survival factor NF-kappab in PC12 cells. J Neurosci Res 61 (2000) 21-32
8. Brauch R., El-Masri M., Parker J., and El-Mallak R. Glial cell number and neuron/glial cell ratios in postmortem brains of bipolar individuals. J Affect Disord 91 (2006) 87-90
9. Campbell S., and McQueen G. An update on regional brain volume differences associated with mood disorders. Curr Opin Psychiatry 19 (2006) 25-33
10. Cunha A., Frey B., Andreazza A.C., Goi J., Rosa A.R., Goncalves C.A., et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Curr Opin Psychiatry 398 (2006) 215-219
11. Evans D., Charney D., Lewis L., Golden R.N., Gorman J.M., Krishnan K.R., et al. Mood disorders in medically ill: scientific review and recommendations. Biol Psychiatry 58 (2005) 175-189
12. Furuno T., and Nakanishi M. Neurotrophic factors increase tumor necrosis factor-α-induced nuclear translocation of NF-κB in rat PC 12 cells. Neurosci Lett 392 (2006) 240-244
13. Gosselin D., and Rivest S. Role of IL-1 and TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system. Brain Behav Immun 21 (2007) 281-289
14. Ichiyama T., Okada K., Liptons J.M., Matsubara T., Hayashi T., and Furukawa S. Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappab. Brain Res 857 (2000) 246-251
15. Irwin M., and Miller A. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 21 (2007) 374-383
16. Jope R.S., and Bijur G.M. Mood stabilizers, glycogen synthase kynase-3β and cell survival. Mol Psychiatry 7 (2002) S35-S45
17. Kim J.W., Jun T.Y., Pae C.U., and Lee K.U. Association Study of Tumor Necrosis Factor-Alpha Gene Polymorphism in schizophrenia and bipolar disorder. J Korean Neuropsychiatr Assoc 42 (2003) 559-563
18. Kim Y., Jung H., Mynt A., Kim H., and Park S. Imbalance between proinflammatory cytokines in bipolar disorder. J Affect Disord 104 (2007) 91-95
19. Kim Y., Na K.S., Shin K.H., Jung H.Y., Choi S.H., and Kim J.B. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 31 (2007) 1044-1053
20. Kim Y, Lee SW, Kim SH, Shim SH, Han SW, Choi SH, et al. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Progress Neuro-psychopharmacol Biol Psychiatry in press. doi: 10.1016/ j.jad.2007.02.018.
21. Kronfol Z., and Remick D. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157 (2000) 683-694
22. Kupfer D.J. The increasing medical burden in bipolar disorder. JAMA 293 (2005) 2528-2530
23. Larson S., and Dunn A. Behavioral effects of cytokines. Brain Behav Immun 15 (2001) 371-387
24. Li X., Bijur G., and Jope R. Glycogen synthase kynase-3β, mood stabilizers and neuroprotection. J Bipolar Disord 4 2 (2002) 137-144
25. Manji H., and Duman R. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for development of novel therapeutics. Psychopharmacol Bull 35 2 (2001) 5-49
26. Manji H., Quiroz J., Payne J., Singh J., Lopes B., Viegas J., et al. The underlying neurobiology of bipolar disorder. World Psychiatry 2 (2003) 136-146
27. Martinez-Aran A., Vieta E., Torrent C., Sanchez-Moreno J., Goikolea J.M., Salamero M., et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. J Bipolar Disord 9 (2007) 103-113
28. Mattson M. NF-kappab in the survival and plasticity of neurons. Neurochem Res 30 (2005) 883-893
29. Mattson M., and Meffert M. Roles for NF-KB in nerve cell, plasticity and disease. Cell Death Differ 13 (2006) 852-860
30. McDonald N., Delderfield S., Zhang W., and Taglialatela G. Tumor necrosis factor-alpha- vs. growth factor deprivation promoted cell death: distinct converging pathways. Aging Cell 2 (2003) 245-256
31. Moorhead T.W., McKirdy J., Sussmann J.E., Hall J., Lawrie S.M., Johnstone E.C., and McIntosh A.M. Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 62 (2007) 894-900
32. Mur M., Portella M.J., Martinez-Aran A., Pifarre J., and Vieta E. Persistent neuropsychological deficit in euthymic bipolar patients: executive function as a core deficit. J Clin Psychiatry 68 (2007) 1078-1086
33. Nemeth Z., Deicht E., Szabó C., Fekete Z., Hauser C., and Haskó G. Lithium induces NF-κB activation and interleucin-8 production in human intestinal epithelial cells. J Biol Chem 277 (2002) 7713-7719
34. O'Brien S.M., Scully P., Scott L.V., and Dinan T.G. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord 90 (2006) 263-267
35. Pae C.U., Lee K.U., Han H., Serretti A., and Jun T.Y. Tumor necrosis factor alpha gene-G308A polymorphism associated with bipolar I disorder in Korean population. Psychiatry Res 125 (2004) 65-68
36. Pan W., and Kastin A. Penetration of neurotrophins and cytokines across the blood-brain/blood-spinal cord barrier. Adv Drug Deliv Rev (1999) 291-298
37. Pasic J., Levy W., and Sullivan M. Cytokines in depression and heart failure. Psychos Med 65 (2003) 181-193
38. Phillips M.L., and Vieta. Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V. Schizophr Bull 33 (2007) 893-904
39. Post R. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res 41 (2007) 979-990
40. Raison C.L., Capuron L., and Miller A. Cytokines sing the blues: inflammation and pathogenesis of depression. Trends Immunol 27 (2006) 24-31
41. Rajkowska G. Altered numbers of cells in mood disorders. Biol Psychiatry 48 (2000) 766-777
42. Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord 4 (2002) 105-116
43. Rajkowska G. Depression: what we can learn from postmortem studies. Neuroscientist 9 4 (2003) 273-284
44. Rajkowska G., Halaris A., and Selemon L. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 49 (2001) 741-752
45. Robinson L., and Ferrier I. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. J Bipolar Disord 8 (2006) 103-116
46. Schiepers O., Whichers M., and Maes M. Cytokines and major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 29 (2005) 201-217
47. Schloesser R., Huang J., Klein P., and Manji H. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology (2007) 1-24
48. Seilhean D., Kobayashi K., He Y., Ushihara T., Rosenblum O., Katlama C., et al. Tumor necrosis factor-α, microglia and astrocytes in AIDS dementia complex. Acta Neuropathol 93 (1997) 508-517
49. Soares J.C., Kochunov P., Monkul E.S., Nicoletti M.A., Brambilla P., Sassi R.B., et al. Structural brain changes in bipolar disorder using deformation field morphometry. Neuroreport 16 (2005) 541-544
50. Strakowski S., Wilson D., Tohen M., Woods B.T., Douglass A.W., and Stoll A.L. Structural brain abnormalities in first-episode mania. Biol Psychiatry 33 (1993) 602-609
51. Strakowski S., DelBello M., Zimmerman M., Getz G., Mills N., Ret J., et al. Ventricular and periventricular structural volumes in first-versus multiple-episode bipolar disorder. Am J Psychiatry 159 (2002) 1841-1847
52. Strakowski S.M., Adler C.M., and DelBello M.P. Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder?. Bipolar Disord 4 (2002) 80-88
53. Sui Z., Sniderhan L., Fan S., Karzmierczak K., Reisinger E., Kovacz A., et al. Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3 β to antagonize nuclear factor-κB survival pathway in neurons. Europ J Neurosc 23 (2006) 2623-2634
54. Sun Z., and Anderson R. NF-κb activation and inhibition: a review. Shock 18 (2002) 99-106
55. Sun Y., Zhang L., Johnston N., Torrey E., and Yolken R. Serial analysis of gene expression in the frontal cortex of patients with bipolar disorder. Br J Psychiatry 178 Suppl 41 (2001) s137-s141
56. Tobinick E., Gross H., Weinberger A., and Cohen H. TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study. Med Gen Med 8 (2006) 25
57. Uranova N., Vostrikov V., Orlovskaya D., and Rachmanova V. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67 (2004) 269-275
58. Yang K., Xie G., Zhang Z., Wang C., Li W., Zhou W., et al. Levels of serum interleukin (IL)-6, IL-1beta, tumor necrosis factor-alpha and leptin and their correlation in depression. Austr N Z J Psychiatry 41 (2007) 266-273